SPAGGIARI, LORENZO
SPAGGIARI, LORENZO
Dipartimento di Oncologia ed Emato-Oncologia
Characterizing the Learning Curve of ION Robotic Bronchoscopy: A CUSUM-Based Analysis of Diagnostic Yield
2026 J. Guarize, L. Bertolaccini, C. Bardoni, S.M. Donghi, L. Spaggiari
The Actual Role of CPET in Predicting Postoperative Morbidity and Mortality of Patients Undergoing Pneumonectomy
2025 A. Mazzella, R. Orlandi, P. Maisonneuve, C. Uslenghi, M. Chiari, M. Casiraghi, L. Bertolaccini, G. Caffarena, L. Spaggiari
Surgical Outcomes After Neoadjuvant Chemo-Immunotherapy for Stage III NSCLC: A Systematic Review and Meta-Analysis
2025 C. Bardoni, M. Chiari, L. Bertolaccini, C. Diotti, A. De Fabiani, G. Nicolosi, A. Mazzella, M. Casiraghi, L. Spaggiari
The Short-Term Impact of Neoadjuvant Chemotherapy on the Outcome of Patients Undergoing Pneumonectomy for Lung Cancer: Is It Acceptable Nowadays?
2025 A. Mazzella, S. Maiorca, G. Nicolosi, P. Maisonneuve, A. Passaro, M. Casiraghi, L. Bertolaccini, F. De Marinis, L. Spaggiari
Unmasking the mimic: lipoid pneumonia imitating primary lung cancer - a case report series of a diagnostic challenge
2025 S. Mohamed, L. Bertolaccini, M. Lombardi, C. Di Tonno, A. Sabalic, M. Casiraghi, L. Spaggiari
Pleurectomy/decortication versus extrapleural pneumonectomy in pleural mesothelioma: a systematic review and meta-analysis of survival, mortality, and surgical trends
2025 M. Brivio, M. Chiari, C. Bardoni, A. Mazzella, M. Casiraghi, L. Spaggiari, L. Bertolaccini
Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma: signal or noise?
2025 L. Bertolaccini, F. De Marinis, L. Spaggiari
Redefining resectability: Bridging perspectives in stage III NSCLC management
2025 L. Bertolaccini, M. Casiraghi, A. Mazzella, L. Spaggiari
Impact of Surgical extent on survival in pulmonary typical carcinoids: a retrospective analysis
2025 L. Bertolaccini, L. Benini, F. Spada, E. Pisa, R. Lobrano, J. Guarize, G. Caffarena, M. Chiari, M. Casiraghi, N. Fazio, L. Spaggiari
Recommendations for the standardization and management of prolonged air leaks in lung surgery
2025 F. Zaraca, M.D. Pipitone, F. Augustin, A. Abdellateef, M. Jiménez, A. Kirschbaum, C.S.H. Ng, D. Nachira, I. Opitz, C. Uslenghi, M. Lucchi, R. Crisci, R. Perkmann, L. Spaggiari, L. Bertolaccini
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME)
2025 C. Catania, S. Manglaviti, P. Zucali, M. Perrino, E. Ruffini, L. Di Tommaso, A. Mazzella, L. Spaggiari, A. Delmonte, G. Lo Russo, M. Garassino, P. Solli, G. Pasello, L. Rosso, F. Lococo, G. Rindi, S. Ricciardi, F. Picozzi, P. Lyberis, B. Tinterri, L. Pala, F. Conforti, T. De Pas
PREDICTIVE SCORE FOR LOCAL RELAPSE AFTER PULMONARY METASTASECTOMY
2025 E. Prisciandaro, L. Bertolaccini, S. Fieuws, A. Cara, L. Spaggiari, L. Huang, R.H. Petersen, M. Lucchi, M.G. Mastromarino, A. Barbarossa, P. De Leyn, M. Roffinella, E. Ruffini, A. Donlagic, M. Gonzalez, M.G. Fuentes-Gago, C. Forcada-Barreda, M.T. Congedo, S. Margaritora, Y. Belaroussi, M. Thumerel, J. Tricard, P. Felix, N. Lebeda, I. Opitz, A. De Palma, G. Marulli, C. Braggio, P.A. Thomas, F. Mbadinga, J.-. Baste, B. Sayan, B. Yildizeli, J. Dekervel, D.E. Van Raemdonck, W. Weder, L.J. Ceulemans
The impact of SMARCA4 loss in non-small cell lung cancer therapy
2025 M. Lombardi, M. D'Ercole, V. Midolo De Luca, M. Chiari, L. Spaggiari, L. Bertolaccini
Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis
2025 L. Bertolaccini, G. Caffarena, F. Spada, L. Benini, E. Pisa, R. Lobrano, M. Chiari, V. Midolo De Luca, J. Guarize, M. Casiraghi, N. Fusco, N. Fazio, L. Spaggiari
10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
2025 M. Casiraghi, R. Orlandi, A. Mazzella, L. Girelli, G. Caffarena, M. Chiari, L. Bertolaccini, G. Lo Iacono, C. Diotti, C. Bardoni, P. Maisonneuve, L. Spaggiari
Biological staging in early-stage non-small-cell lung cancer: molecular risk-guided adjuvant therapy
2025 L. Bertolaccini, L. Spaggiari
Neoadjuvant Chemoimmunotherapy in Stage III Non-Small Cell Lung Cancer
2025 L. Bertolaccini, F. De Marinis, L. Spaggiari
Fast Track Pathway for Lung Cancer: The Integration of ION Robotic-Assisted Bronchoscopy With Robotic Thoracic Surgical Resection
2025 J. Guarize, L. Bertolaccini, L. Spaggiari
Reflections on the ThoRN Consensus: Toward a Multidisciplinary Integration
2025 L. Bertolaccini, C. Bardoni, M. Casiraghi, L. Spaggiari
239P Dual AI models for perioperative decision support in resectable NSCLC: A real-world cohort analysis
2025 C. Bardoni, L. Bertolaccini, J. Guarize, M. Casiraghi, G. Lo Iacono, M. Chiari, C. Diotti, A. Mazzella, S.M. Donghi, R. Gasparri, S. Mohamed, V.A. Artuso, G. Caffarena, L. Spaggiari